Search
for

    Sort by

    Research 151–180 of 374

    1. Psoriasis Drugs & Therapy Perspectives · 1994
    2. Alopecia - the search for novel agents continues Expert Opinion on Therapeutic Patents · 1997 · 11 citations
    3. Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists Dermatology and Therapy · 2025
    4. Update on Melasma—Part I: Pathogenesis Dermatology and Therapy · 2022 · 10 citations
    5. Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome Therapeutics and clinical risk management · 2008 · 52 citations
    6. Polycystic Ovary Syndrome: Management of a Long-Term Condition in Primary Care Cambridge University Press eBooks · 2017 · 2 citations
    7. Alopecia and hirsutism* Clinical and Experimental Dermatology · 1982 · 6 citations
    8. 11 Treatment of hirsutism and acne with cyproterone acetate Clinics in Endocrinology and Metabolism · 1986 · 43 citations
    9. Hirsutism – From Diagnosis to Use of Antiandrogens Frontiers of Hormone Research · 2012 · 9 citations
    10. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism Journal of Steroid Biochemistry · 1975 · 232 citations
    11. Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases Oncotarget · 2016 · 24 citations
    12. SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA International Journal of Innovative Technologies in Social Science · 2025
    13. Hirsutism and virilization Postgraduate medicine · 1995 · 13 citations
    14. Obesity and female androgenic alopecia: A cause and an effect? Journal of The American Academy of Dermatology · 1994 · 7 citations
    15. Cyproterone Acetate: A Genotoxic Carcinogen? Pharmacology & Toxicology · 2001 · 1 citations
    16. Un nuevo anovulador antiandrogénico Revista Colombiana de Obstetricia y Ginecología · 1982
    17. Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review Endocrine Reviews · 2008 · 343 citations
    18. Dermatologic Manifestations of Polycystic Ovary Syndrome American Journal of Clinical Dermatology · 2007 · 76 citations
    19. Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study BMJ · 2021 · 59 citations
    20. Analysis of hormone antagonists in clinical and municipal wastewater by isotopic dilution liquid chromatography tandem mass spectrometry Analytical and Bioanalytical Chemistry · 2010 · 51 citations
    21. 5α-Reduced glucocorticoids: a story of natural selection Journal of Endocrinology · 2011 · 46 citations
    22. Clinical, hormonal and metabolic parameters in women with PCOS with different combined oral contraceptives (containing chlormadinone acetate versus drospirenone) Journal of Endocrinological Investigation · 2019 · 25 citations
    23. Guidelines for the Use of Acitretin in Psoriasis Actas Dermo-Sifiliográficas · 2013 · 25 citations
    24. Contraception and the dermatologist Journal of The American Academy of Dermatology · 2013 · 22 citations
    25. Pharmacologic Treatment of Polycystic Ovary Syndrome Seminars in reproductive medicine · 2003 · 21 citations
    26. Menopausal Acne – Challenges And Solutions International Journal of Women's Health · 2019 · 14 citations
    27. A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus Revista Brasileira de Ginecologia e Obstetrícia · 2018 · 12 citations
    28. The use of cyproterone acetate/ethinyl estradiol in hyperandrogenic skin symptoms – a review The European Journal of Contraception & Reproductive Health Care · 2017 · 11 citations
    29. Pharmacological management of polycystic ovary syndrome Australian Prescriber · 2024 · 9 citations
    30. Effects of oral contraceptives on the quality of life of women with polycystic ovary syndrome: a crossover randomized controlled trial Health and Quality of Life Outcomes · 2020 · 7 citations